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The direct detection of an antibody–peptide complex is reported by matrix-assisted laser
desorption ionization mass spectrometry (MALDI-MS). Experimental conditions have been
found in which specific, noncovalent interactions in solution are maintained throughout the
sample preparation and ionization process. Mass measurements based on the ion signals for
the intact antibody and 1:1 antibody–peptide complex reveal that specific noncovalent
associations between a monoclonal antibody and a peptide, which comprises the determinant
of the corresponding antigen, are maintained in the gas phase. These results support the wider
application of MALDI-MS to studies of the structure and specificity of macromolecular
complexes important to immune and other biological function. (J Am Soc Mass Spectrom
2000, 11, 746–750) © 2000 American Society for Mass Spectrometry
The basis of the interaction between an antigen andantibody lies in the complementary shape of eachmolecule in the vicinity of their binding sites [1].
The highly specific nature of these interactions arises
through the contact of the molecular surfaces of antigen
and antibody that constitute an epitope and paratope,
respectively. Water is generally excluded from the
binding site, and antigen–antibody complexes are sta-
bilized through electrostatic interactions, hydrogen
bonding, hydrophobic and Van der Waals forces. Anti-
gen–antibody complexes are among the strongest non-
covalent complexes known with association constants
in solution on the order of 109 M21 [2]. The formation of
these macromolecular complexes plays an essential role
in immune function [3].
Recent evidence has shown that noncovalent pro-
tein–protein [4, 5] and other macromolecular complexes
[6, 7] can be detected by both electrospray ionization
(ESI) [8, 9] and matrix-assisted laser desorption ioniza-
tion mass spectrometry (MALDI-MS) [10–14]. The elec-
trospray technique has been most widely employed in
these studies since the ionization method proceeds with
the transfer of macromolecules or their complexes di-
rectly from solution to the gas phase. ESI experiments
can be carried out using aqueous solutions containing
volatile buffers to maintain physiological or other pH
that preserve the integrity of the complex in solution.
The MALDI approach, on the other hand, generally
involves the crystallization of an analyte with a large
molar excess of organic chromophore onto a solid
support. This feature of the MALDI sample preparation
process would intuitatively appear to be denaturing so
that, at best, only the most stable noncovalent com-
plexes could be preserved and ultimately detected.
Despite some perceived limitations of MALDI-MS
for these studies, a growing number of reports have
demonstrated that noncovalent protein–protein and
other macromolecular complexes can be detected [10–
16]. These include studies of the self-association of
proteins to examine the stoichiometry of protein com-
plexes by mass spectrometry. As an example, the self-
association of streptavidin has been observed by
MALDI-MS with the detection of dimeric, trimeric, and
tetrameric forms of the protein [10]. In support of the
postulate that these complexes survive the sample prep-
aration procedure, the addition of ethanol as a denatur-
ant to the matrix solution resulted in the exclusive
detection of the monomeric form [10], although forma-
tion of the complex has been shown more recently to be
highly dependent on the matrix and solvent systems
used in preparation of the sample for analysis [13].
There are, however, very few reports of the identifi-
cation of specific noncovalent complexes of macromol-
ecules in the gas phase [11, 15]. Matrix [13, 17] and other
sample conditions [4, 5, 13] dramatically affect the
ability to detect noncovalent complexes by MALDI-MS.
In addition, a so-called “first shot” phenomenon has
been reported [10, 13] whereby protein complexes have
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been observed only upon irradiation of a previously
unirradiated sample spot. Subsequent irradiation of the
same spot results in the detection of protein ions in their
monomeric form.
We have recently shown in the course of the devel-
opment of a mass spectrometric based immunoassay
that specific noncovalent antibody–peptide complexes
can be preserved on the sample surface during
MALDI-MS [18, 19]. The success of this assay lies in the
ability to ionize and detect nonbinding peptides pref-
erentially over those that are associated to immuno-
globulin molecules. Thus epitopic peptides can be iden-
tified based on the absence or reduced intensity of their
ion signals in the MALDI mass spectrum of an antibody
reaction mixture relative to an unreacted control. This
has been achieved in the case of a complex biological
mixture at the femtomole sample level [19]. Here spec-
tra were acquired by averaging those obtained for a
large number of laser shots to improve data quality and
ion statistics.
The development of this approach suggests that
specific antibody–peptide complexes are preserved on
the MALDI sample surface throughout the deposition
process and ionization event. The sample preparation
and ion extraction conditions employed in our previous
studies [18,19], however, favored the detection of pep-
tide ions over high molecular weight species and no
attempt was made to directly detect gas-phase anti-
body–peptide complexes. Here we report the first,
direct detection of a noncovalent antibody–peptide
complex by MALDI-MS. Importantly, we demonstrate
that specific antibody–peptide associations formed in
solution can be maintained and detected in the form of
gas-phase ion complexes.
Experimental
Immunochemistry
A 1:1 mixture (each at 25 mM) of a synthetic analog of
the epitopic peptide from the hemagglutinin antigen of
a type A influenza viral strain [19] and nonbinding
adrenocorticotropic hormone (ACTH) fragment 18–39
were reacted with monoclonal antiinfluenza IVC102
(Research Diagnostics, Flanders NJ) (10 mM) in 50 mM
Tris hydrochloride (10 mL; pH 7.8) containing 150 mM
sodium chloride for a period of 2 h at 25 °C.
Sample Preparation
A matrix surface was prepared by applying a solution
of a-cyano-4-hydroxycinnamic acid in acetone (10 mg/
mL, 1 mL) to the sample plate and allowing the solvent
to evaporate in air. An aliquot of the reaction mixture (1
mL) was added to this surface and dried using a
variable temperature heat gun (Master Appliance,
Racine WI) mounted vertically over the plate. The
deposited sample was washed of excess salt by placing
a drop of water (1–5 mL) on the surface and removing it
with a pipette after 10–20 s. Finally, an additional
solution of a-cyano-4-hydroxycinnamic acid (1 mL) in
acetonitrile and water (saturated in 30:70 by volume)
was added and the surface again heat dried.
Mass Spectrometry
MALDI-MS was performed on a Voyager STR reflecting
time-of-flight mass spectrometer (PE Biosystems, Fram-
ingham MA) equipped with a 337 nm nitrogen laser
operating in the linear, positive ion mode with an
accelerating voltage of 1 25 kV and an extraction delay
of 500 ns. A timed ion selector was used to deflect ions
of low m/z (,500) from the detector. Spectra were
acquired by averaging data of approximately 80–100
laser shots to improve data quality and ion statistics.
Mass spectra were calibrated internally by assigning
m/z for the multiply charged ions for the intact immu-
noglobulin derived from a molecular weight measure-
ment for the monoclone in separate experiments using
the singly protonated ions for trypsinogen and bovine
serum albumin as internal mass standards. Peak areas
were measured using the program utilities Interpol and
Integrat running within the GRAMS processing soft-
ware (Galactic Industries Corporation, Salem NH).
Results and Discussion
We have investigated the preservation and detection of
specific antibody–peptide complexes by MALDI-MS in
the case of a monoclonal antibody to the hemagglutinin
antigen of a type A influenza strain. This monoclone
has previously been shown to bind a determinant
comprising residues of 207–225 of the antigen (AIYHT-
ENAYVSVVSSHYNR), a region which forms part of a
highly accessible domain atop the homotrimeric com-
plex on the surface of the viral particle [19]. In the same
study, a peptide composed of residues 18–39 of the
ACTH (RPVKVYPNGAEDESAEAFPLEF) was shown
not to bind to the antibody.
A MALDI mass spectrum for the unreacted mono-
clonal antibody is shown in Figure 1a. The matrix
a-cyano-4-hydroxycinnamic acid was used exclusively
in these studies since it promotes the formation of
multiply charged ions and afforded spectral data of the
best quality in terms of mass resolution and signal to
noise in the detection of the monoclonal antibody.
Under the particular conditions employed, a distribu-
tion of multiply protonated species is observed corre-
sponding to ions [M 1 zH]z1 where z 5 21–91. An
average molecular weight for the antibody was mea-
sured to be 147 986 6 33 based on the m/z obtained for
the most abundant ions (z 5 21– 61) in experiments
in which singly protonated ions for the proteins
trypsinogen and bovine serum albumin, added to the
antibody solution, were used as internal mass stan-
dards. Measured and predicted m/z for the dominant
ion signals for the monoclone are shown in Table 1. The
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predicted values are calculated based on the average
molecular weight measured.
The MALDI mass spectrum of the same monoclonal
antibody after reaction with an equimolar mixture of
the peptide determinant of hemagglutinin and a non-
binding control peptide is shown in Figure 1b. It is
immediately apparent that the peak widths for the
multiply charged ions increase, and additional mass-
resolved peaks are clearly evident at higher m/z across
charge states z 5 21– 61, consistent with the detection
of an antibody–peptide complex. The centroid m/z
values measured for these peaks, based on the assign-
ment of the predicted m/z for two multiply charged ions
(21 and 51) of the intact monoclonal antibody, are
shown in Table 1. The average molecular weight differ-
ence between that measured for the unreacted mono-
clone and the complex is determined to be 2238 6 33
consistent with the theoretical mass of the hemaggluti-
nin derived peptide (Mav 2210) and not that for the
ACTH peptide (Mav 2466).
As can be seen from the data of Table 1, the deviation
in the measured molecular weight of the associated
peptide and its true value is contributed largely to the
m/z for the antibody–peptide complex at [M 1 5H]51
species. This is despite the fact that the m/z value for the
[M 1 5H]51 ion of the intact antibody was used to mass
Figure 1. (a) MALDI mass spectrum of a monoclonal anti-influenza antibody to the hemagglutinin
antigen; (b) MALDI mass spectrum of the antibody after reaction with an equimolar mixture of the
peptide determinant of hemagglutinin and a nonbinding control peptide.
748 KISELAR AND DOWNARD J Am Soc Mass Spectrom 2000, 11, 746–750
calibrate this spectrum (Figure 1b). We attribute the
deviation in the measured mass of the bound peptide to
be associated with the peak shape for the ion signal of
the complex at this charge state. Separate calibration
procedures in which the m/z ratio for the [M 1 6H]61
ion for the intact antibody was used to calibrate the
spectrum resulted in a similar deviation in mass at the
51 charge state.
Further evidence for the preferential binding of the
hemagglutinin peptide comes from a measure of the
relative ion intensity for the two peptides in the low m/z
region of the spectrum before and after reaction with
the monoclone. The mass spectrum shown in Figure 1b
is presented in Figure 2 over a larger m/z range. The
inset clearly shows that the ion signal for the hemag-
glutinin peptide is substantially less than that for the
larger nonbinding peptide. Measurements from five
separate mass spectra reveal that the area under the
[M 1 H]1 ion signal for the hemagglutinin peptide
relative to the larger ACTH peptide is 26%. This con-
trasts with the ion signals observed for the same pep-
tide mixture recorded in the absence of the monoclone
(Figure 3) under the same experimental conditions.
Here the average relative peak area is measured to be
63% through repeated experiments. Thus the dimin-
ished ion intensity for the peptide derived from the
hemagglutinin antigen is consistent with it binding to
the monoclonal antibody resulting in the detection of a
1:1 antibody–peptide complex.
Conclusions
We have reported the direct detection of a specific
antibody–peptide complex by MALDI-MS. Consistent
with our previous observations [18, 19], we have shown
that antibody–peptide complexes can survive MALDI
sample preparation techniques and the ionization
event. Here, using conditions conducive with the direct
analysis and detection of an intact monoclonal anti-
body, we have demonstrated the existence of antibody–
peptide complexes in the gas phase. Importantly, spe-
cific antibody–peptide complexes formed in solution
Table 1.
Charged ion
m/z valuesa measured for
antibody from calibration
with internal protein
mass standardsb
m/z predicted based on
average molecular weight
determined from
measured mass-to-charge
m/z values measured for
ions associated with
antibody–peptide complex
Molecular weight of
associated peptide
of antibody–peptide
complex
[M 1 2H]21 74 005.3 6 10.4 73 993.9 6 17.1c 75 095.4 2203 6 34
[M 1 3H]31 49 338.4 6 20.6 49 329.6 6 11.0 50 067.5 2198 6 34
[M 1 4H]41 37 005.2 6 4.7 36 997.5 6 8.3 37 567.3 2214 6 33
[M 1 5H]51 29 595.3 6 3.1 29 598.2 6 6.6c 30 071.7 2368 6 33
[M 1 6H]61 24 654.8 6 7.6 24 665.3 6 5.5 25 034.3 2206 6 33
aRepresents an average of measured m/z values from four separate mass spectra.
b[M 1 H]1 ions for proteins trypsinogen and bovine serum albumin were assigned to their theoretical values to calibrate the spectra.
cm/z values used to internally calibrate mass spectrum of antibody–peptide complex [Figure 1(b)].
Figure 2. Mass spectrum of Figure 1(b) shown over a full m/z range. Insert shows the relative ion
intensity for the [M 1 H]1 ions for each peptide of the mixture after reaction with antibody.
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are shown to be maintained in the gas phase. This may
enable an immunoassay to be developed in which
protein epitopes are identified directly through the
analysis of an antibody–peptide complex. We are pres-
ently exploring the applicability of these results to more
complex peptide mixtures.
Further our results add to a very limited number of
studies in which specific noncovalent macromolecular
associations have been identified by MALDI-MS [11,
15]. Specific antibody–peptide complexes have been
shown to be preserved [18, 19] and are detected in this
study by MALDI-MS. These complexes have been de-
tected after averaging spectral data obtained from a
large number of laser shots and the first-shot phenom-
enon [10, 13], in which it is postulated that complexes
embeded in the matrix in the interior of the sample are
prone to dissociation [13], appears not to prevail here.
Indeed, the MALDI sample has been prepared in this
study in such a manner so as to coat the antibody–
peptide complex with additional a-cyano-4-hydroxy-
cinnamic acid matrix compound after deposition.
Further studies are necessary to examine the precise
role of the matrix, solution, sample preparation, and ion
extraction conditions for the preservation of specific
noncovalent interactions within a mass spectrometer,
but MALDI-MS is expected to play a larger role in
future studies of the structure of immune complexes, in
particular, and macromolecular complexes in general.
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